Roche Venture Fund

The Roche Venture Fund is the corporate venture capital arm of Roche, a global leader in pharmaceuticals and diagnostics. It invests in life science companies aiming to create value by fostering innovation, guiding successful businesses, and generating financial returns to Roche. The fund is an evergreen fund with CHF 750 million available, focusing on private companies with innovative medicines, diagnostics, and technologies. It typically invests CHF 3-10 million in the first financing round, seeking a 15% ownership stake, and reserves funds for follow-on financing rounds. The team is based in Basel, Switzerland, and South San Francisco, USA.

The fund's investment strategy emphasizes active involvement within portfolio companies, providing not just funding but also expertise and a long-term vision to drive shared success. It co-invests with leading venture funds, including other corporate venture funds, on a regular basis. The Roche Venture Fund has invested in over 60 companies globally, with a current portfolio of more than 30 companies located in 10 countries across Europe, North America, and the Pacific Region.

By leveraging Roche's extensive resources and industry knowledge, the fund aims to accelerate the development of innovative life science companies, contributing to advancements in healthcare and delivering value to patients worldwide.